InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Blackford Gary, 董事. Insider active across 3 companies, notably ReShape Lifesciences Inc.. Aggregated, 9 reports have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €187k. History available since 22 July 2021. The latest transaction was filed on 27 July 2026 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Blackford Gary
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
40,000 股@ US$25.000.085% mcap31.2% 占其流量Common StockSEC:0001606498-26-000105:0
79,590 股@ US$25.000.17% mcap62.1% 占其流量Common StockSEC:0001606498-26-000105:1
20,000 股@ US$10.975100.0% 占其流量Common StockSEC:0001606498-25-000111:0
标准退出：2025年11月11日 (T+90)
12,003 股0Common StockSEC:0001606498-25-000016:0
8,378 股0Common StockSEC:0001606498-24-000013:0
7,008 股0Common StockSEC:0001606498-23-000006:0
5,354 股0Common StockSEC:0001606498-22-000007:0
253,429 股0Common Stock, $0.001 par value per shareSEC:0001790300-21-000008:0
4,274 股Common StockSEC:0001209191-16-089552:0
9 条申报中的 9 条
About Blackford Gary
BLACKFORD GARY is Administrateur at Avanos Medical, INC., ReShape Lifesciences Inc., and Halyard Health, Inc. The 9 filings on record span the period from 2016-01-06 to 2026-07-28, and, across the sampled recent filings, purchases total EUR 187400 and sales total EUR 2620516.
